In just the first fews days following the Presidential election victory of Donald Trump, the response has already been ...

Indices traded most of the session in the green before the Trump statement, led by gains in Tesla and Meta post their ...

While the demand is there, it's clear that's not the sole reason why Nvidia's RTX 50 series is impossible to find in stores.

The tech giant’s sales of apps and services helped profit grow 7 percent from a year ago, even as the company contended with ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Meta and Tesla shares rally. Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

We recently compiled a list of the Top 10 AI News and Ratings You Probably Missed. In this article, we are going to take a ...

The line between dividend stocks and non-dividend tech stocks is now blurrier than ever, as 71% of the Magnificent 7 now pay ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

European stock markets rose Thursday as the European Central Bank cut interest rates again while US shares were steady after a mixed bag of company earnings reports.

Tesla’s fourth-quarter adjusted profits rose slightly amid a big push to sell its electric vehicles with offers of zero financing and other incentives, but the<a class="excerpt-read-more" href=" More ...

AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...